Several investigational products targeting ATTR amyloid are being studied in clinical trials. These include small interfering RNA (siRNA) molecules which reduce the production of the amyloid precursor misfolded protein and ATTR stabilization molecules.
Cardiac amyloidosis future or investigational therapies
Dilated cardiomyopathy future or investigational therapies
Cardiomegaly future or investigational therapies
Cardiac amyloidosis medical therapy
Atherosclerosis future or investigational therapies
Chronic stable angina treatment lipid management
Right heart failure future or investigational therapies
Chronic stable angina treatment diabetes control